AYTU BIOPHARMA INC COM USD0.0001 (POST REV SPLIT) earnings per share and revenue

0A8M earnings per share for the last quarter are -0.20 USD whereas the estimation was -0.34 USD which accounts for 41.18% surprise. Company revenue for the same period amounts to 16.57 M USD despite the estimated figure of 13.77 M USD. Estimated earnings per share for the next quarter are -0.28 USD, and revenue is expected to reach 15.55 M USD. Also watch annual changes over time to get a bigger picture of 0A8M earnings per share and revenue dynamics.